🔎 Trials Near Me

Dachaigh › Amyloidosis › North Carolina

Sgrùdaidhean clionaigeach Amyloidosis ann an North Carolina

Tha 10 sgrùdaidhean airson Amyloidosis a’ lorg phàirtichean aig làraichean ann an North Carolina.

Bailtean ann an North Carolina

Teacsa sgrùdaidh oifigeil (Beurla)

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

  • Levine Cancer Institute, Charlotte
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT05652335

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

  • Research Site, Durham
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 130 · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT06465810

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  • Clinical Trial Site, Charlotte
A’ fastadhÌre 3
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT07052903

TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

  • Clinical Trial Site, Chapel Hill
A’ fastadhÌre 3
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT07223203

DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting

  • Clinical Trial Site, Charlotte
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT07358078

ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)

  • Clinical Trial Site, Durham
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT04561518

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  • Duke University Medical Center, Durham
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT06563895

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion

  • Atrium Health Levine Cancer Institute /ID# 255074, Charlotte
  • Atrium Health Wake Forest Baptist Medical Center /ID# 255851, Winston-Salem
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Cèit 2026 · NCT06158854

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

  • Duke University Medical Center, Durham
A’ fastadhÌre 3
Aoisean 18 gu 90 · Gach gnè · Air ùrachadh 27 Màrt 2026 · NCT06128629

Registry for Adults With Plasma Cell Disorders (PCD's)

  • North Carolina Cancer Hospital, Chapel Hill
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Samh 2025 · NCT03717844

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.